Inactive Instrument
Celator Pharmaceuticals Inc Stock
Stocks
US15089R1023
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 31/05/16 | Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal | RE |
| 31/05/16 | Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Arthur C. Louie
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.62% | +0.50% | +33.92% | +60.07% | 64.38B | |
| +0.35% | +3.04% | +12.64% | +83.62% | 56.16B | |
| +0.53% | +2.55% | +13.90% | +104.77% | 54.16B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 45.33B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.25B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 40.78B | |
| +3.27% | +47.40% | +110.44% | +94.92% | 33.8B | |
| +1.22% | -1.39% | +13.92% | +46.95% | 32.25B | |
| -1.29% | -1.72% | +21.00% | -6.85% | 23.57B | |
| Average | +0.08% | +4.72% | +52.71% | +163.93% | 43.63B | |
| Weighted average by Cap. | +0.01% | +3.64% | +49.44% | +162.23% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
